                         SEQUENCE LISTING

<110>  Mirkin, et al.
 
<120>  POLYVALENT RNA-NANOPARTICLE COMPOSITIONS

<130>  30938/28168

<150>  US-61/117,449
<151>  2008-11-24

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  25
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Phosphate

<220>
<221>  misc_structure
<222>  (25)..(25)
<223>  36 Carbon spacer bound to thiol group

<400>  1
cgacuucgug ccagagucuu ucgac                                             25


<210>  2
<211>  27
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligonucleotide

<400>  2
gucgaaagac ucuggcacga agucgua                                           27


<210>  3
<211>  27
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligonucleotide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Cy3

<400>  3
gucgaaagac ucuggcacga agucgua                                           27


<210>  4
<211>  27
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligonucleotide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Cy5

<400>  4
gucgaaagac ucuggcacga agucgua                                           27


<210>  5
<211>  25
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligonucleotide


<220>
<221>  misc_feature
<222>  (25)..(25)
<223>  dabcyl

<400>  5
cgacuucgug ccagagucuu ucgac                                             25


<210>  6
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligonucleotide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Phosphate

<220>
<221>  misc_structure
<222>  (25)..(25)
<223>  36 Carbon spacer bound to thiol group

<400>  6
ggaggacgcu ccagaugaaa ugggt                                             25


<210>  7
<211>  24
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligonucleotide

<400>  7
acccauuuca ucuggagcgu ccug                                              24


